Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eccles

Showing results (181-190 of 340) with videos related to

Pageof 34
Sort By:
Journal of Hazardous Materials|November 28, 2025
Acute toxicity, behaviour, metabolism, and transcriptomic points of departure in embryo-larval zebrafish exposed to nine different PFASHyojin Lee, Jory Curry, John D H Stead, et al.
Plos One|February 2, 2013
Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancerElla R Thompson, Simone M Rowley, Sarah Sawyer, et al.
International Journal of Cancer|April 5, 2008
Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancerMichael P A Davies, Dong Liu Barraclough, Ceri Stewart, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 20, 2025
Lessons learned from evaluating defined chemical mixtures in a high-throughput estrogen receptor assay systemFred Parham, Kristin M Eccles, Cynthia V Rider, et al.
Advances in Therapy|January 27, 2016
Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature ReviewDiana M Eccles, Judith Balmaña, Joe Clune, et al.
Cancer Research|May 1, 1993
p53 mutation is a common genetic event in ovarian carcinomaB J Milner, L A Allan, D M Eccles, et al.
Journal of Medical Genetics|December 5, 2023
Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)Kelly Kohut, Beverley Speight, Julie Young, et al.
Oncogene|October 1, 1992
Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics GroupD M Eccles, S E Russell, N E Haites, et al.
Environmental Pollution (Barking, Essex : 1987)|November 17, 2022
An exploratory spatial contaminant assessment for polar bear (Ursus maritimus) liver, fat, and muscle from northern CanadaV Boutet, M Dominique, K M Eccles, et al.
JCO Precision Oncology|September 14, 2020
Pathogenic Variants in <i>CHEK2</i> Are Associated With an Adverse Prognosis in Symptomatic Early-Onset Breast CancerStephanie L Greville-Heygate, Tom Maishman, William J Tapper, et al.
Pageof 34

Showing results (181-190 of 340) with videos related to

Sort By:
Pageof 34
Journal of Hazardous Materials|November 28, 2025
Acute toxicity, behaviour, metabolism, and transcriptomic points of departure in embryo-larval zebrafish exposed to nine different PFASHyojin Lee, Jory Curry, John D H Stead, et al.
Plos One|February 2, 2013
Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancerElla R Thompson, Simone M Rowley, Sarah Sawyer, et al.
International Journal of Cancer|April 5, 2008
Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancerMichael P A Davies, Dong Liu Barraclough, Ceri Stewart, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 20, 2025
Lessons learned from evaluating defined chemical mixtures in a high-throughput estrogen receptor assay systemFred Parham, Kristin M Eccles, Cynthia V Rider, et al.
Advances in Therapy|January 27, 2016
Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature ReviewDiana M Eccles, Judith Balmaña, Joe Clune, et al.
Cancer Research|May 1, 1993
p53 mutation is a common genetic event in ovarian carcinomaB J Milner, L A Allan, D M Eccles, et al.
Journal of Medical Genetics|December 5, 2023
Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)Kelly Kohut, Beverley Speight, Julie Young, et al.
Oncogene|October 1, 1992
Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics GroupD M Eccles, S E Russell, N E Haites, et al.
Environmental Pollution (Barking, Essex : 1987)|November 17, 2022
An exploratory spatial contaminant assessment for polar bear (Ursus maritimus) liver, fat, and muscle from northern CanadaV Boutet, M Dominique, K M Eccles, et al.
JCO Precision Oncology|September 14, 2020
Pathogenic Variants in <i>CHEK2</i> Are Associated With an Adverse Prognosis in Symptomatic Early-Onset Breast CancerStephanie L Greville-Heygate, Tom Maishman, William J Tapper, et al.
Pageof 34